These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30372491)

  • 1. Alteration of Flt3-Ligand-dependent de novo generation of conventional dendritic cells during influenza infection contributes to respiratory bacterial superinfection.
    Beshara R; Sencio V; Soulard D; Barthélémy A; Fontaine J; Pinteau T; Deruyter L; Ismail MB; Paget C; Sirard JC; Trottein F; Faveeuw C
    PLoS Pathog; 2018 Oct; 14(10):e1007360. PubMed ID: 30372491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection.
    Barthelemy A; Ivanov S; Fontaine J; Soulard D; Bouabe H; Paget C; Faveeuw C; Trottein F
    Mucosal Immunol; 2017 Mar; 10(2):460-469. PubMed ID: 27220813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-Like Receptor 3/TRIF-Dependent IL-12p70 Secretion Mediated by Streptococcus pneumoniae RNA and Its Priming by Influenza A Virus Coinfection in Human Dendritic Cells.
    Spelmink L; Sender V; Hentrich K; Kuri T; Plant L; Henriques-Normark B
    mBio; 2016 Mar; 7(2):e00168-16. PubMed ID: 26956584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
    Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
    Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sharma-Chawla N; Stegemann-Koniszewski S; Christen H; Boehme JD; Kershaw O; Schreiber J; Guzmán CA; Bruder D; Hernandez-Vargas EA
    Front Immunol; 2019; 10():1864. PubMed ID: 31474978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I Interferon Orchestrates Demand-Adapted Monopoiesis during Influenza A Virus Infection via STAT1-Mediated Upregulation of Macrophage Colony-Stimulating Factor Receptor Expression.
    Lin SJ; Lin KM; Chen SJ; Ku CC; Huang CW; Huang CH; Gale M; Tsai CH
    J Virol; 2023 Apr; 97(4):e0010223. PubMed ID: 37022164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice.
    Nakamura S; Davis KM; Weiser JN
    J Clin Invest; 2011 Sep; 121(9):3657-65. PubMed ID: 21841308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections.
    Shepardson KM; Larson K; Johns LL; Stanek K; Cho H; Wellham J; Henderson H; Rynda-Apple A
    Front Immunol; 2018; 9():2589. PubMed ID: 30473701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-22 Immunotherapy during Severe Influenza Enhances Lung Tissue Integrity and Reduces Secondary Bacterial Systemic Invasion.
    Barthelemy A; Sencio V; Soulard D; Deruyter L; Faveeuw C; Le Goffic R; Trottein F
    Infect Immun; 2018 Jul; 86(7):. PubMed ID: 29661933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission.
    Zangari T; Ortigoza MB; Lokken-Toyli KL; Weiser JN
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection.
    Sumitomo T; Nakata M; Nagase S; Takahara Y; Honda-Ogawa M; Mori Y; Akamatsu Y; Yamaguchi M; Okamoto S; Kawabata S
    mBio; 2021 Jun; 12(3):e0326920. PubMed ID: 34061598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased susceptibility for superinfection with Streptococcus pneumoniae during influenza virus infection is not caused by TLR7-mediated lymphopenia.
    Stegemann S; Dahlberg S; Kröger A; Gereke M; Bruder D; Henriques-Normark B; Gunzer M
    PLoS One; 2009; 4(3):e4840. PubMed ID: 19290047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.
    Sharma-Chawla N; Sender V; Kershaw O; Gruber AD; Volckmar J; Henriques-Normark B; Stegemann-Koniszewski S; Bruder D
    Infect Immun; 2016 Dec; 84(12):3445-3457. PubMed ID: 27647871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune responses at the asymptomatic stage of influenza A viral infections of Streptococcus pneumoniae colonized and non-colonized mice.
    Cuypers F; Schäfer A; Skorka SB; Surabhi S; Tölken LA; Paulikat AD; Kohler TP; Otto SA; Mettenleiter TC; Hammerschmidt S; Blohm U; Siemens N
    Sci Rep; 2021 Oct; 11(1):20609. PubMed ID: 34663857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of dendritic cell progenitors to foci of influenza A virus infection sustains immunity.
    Cabeza-Cabrerizo M; Minutti CM; da Costa MP; Cardoso A; Jenkins RP; Kulikauskaite J; Buck MD; Piot C; Rogers N; Crotta S; Whittaker L; Encabo HH; McCauley JW; Allen JE; Pasparakis M; Wack A; Sahai E; Reis e Sousa C
    Sci Immunol; 2021 Nov; 6(65):eabi9331. PubMed ID: 34739343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection.
    Shirey KA; Perkins DJ; Lai W; Zhang W; Fernando LR; Gusovsky F; Blanco JCG; Vogel SN
    mBio; 2019 May; 10(3):. PubMed ID: 31064834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3.
    Speshock JL; Doyon-Reale N; Rabah R; Neely MN; Roberts PC
    Infect Immun; 2007 Jun; 75(6):3102-11. PubMed ID: 17403870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.
    Li Y; Yang Y; Chen D; Wang Y; Zhang X; Li W; Chen S; Wong SM; Shen M; Akerley BJ; Shen H
    mBio; 2023 Aug; 14(4):e0051923. PubMed ID: 37222516
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection.
    Shepardson KM; Larson K; Morton RV; Prigge JR; Schmidt EE; Huber VC; Rynda-Apple A
    mBio; 2016 May; 7(3):. PubMed ID: 27143388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR7 contributes to the rapid progression but not to the overall fatal outcome of secondary pneumococcal disease following influenza A virus infection.
    Stegemann-Koniszewski S; Gereke M; Orrskog S; Lienenklaus S; Pasche B; Bader SR; Gruber AD; Akira S; Weiss S; Henriques-Normark B; Bruder D; Gunzer M
    J Innate Immun; 2013; 5(1):84-96. PubMed ID: 23154432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.